In silico prediction of the specificity of BcR IG clonotypes resulted in the identification of 764 unique SARS-homologous clonotypes within the BcR IG gene repertoires of 66 (81.5%) of 81 individuals who tested positive for COVID-19 during the first pandemic wave (Table S2). The gene discussed is BCR; the disease is COVID-19.